171 – 180 of 2191
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations
(
- Contribution to journal › Scientific review
-
Mark
Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
(
- Contribution to journal › Article
-
Mark
Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973
(
- Contribution to journal › Article
-
Mark
The EHA Research Roadmap : Transfusion Medicine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma : results from a Nordic Lymphoma Group phase II trial
(
- Contribution to journal › Letter
-
Mark
Blood in a Lab: Using Immortalized Erythroid Cell Lines as a Source for Blood Transfusion
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Recent advances in the mechanisms and treatment of immune thrombocytopenia
(
- Contribution to journal › Scientific review
-
Mark
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow-Self Organizing Maps algorithm
(
- Contribution to journal › Article
-
Mark
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
(
- Contribution to journal › Letter